Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-10

Clinical Trial Update: Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer® [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Injectafer for cancer- and chemotherapy-related anemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INJECTAFER (ferric carboxymaltose injection)

Snippet

Sponsor: American Regent, Inc. | Conditions: Cancer and Chemotherapy Related Anemia | Phase 3 | Status: COMPLETED | Results posted: 2021-05-10